气喘垫片市场 - 按产品类型（AeroChamber、OptiChamber、Volumatic、Inspirease）、按配销通路（零售药房、医院药房、线上药房） - 全球预测 2024 年 - 2032 年

Asthma Spacers Market - By Product Type (AeroChamber, OptiChamber, Volumatic, Inspirease), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) - Global Forecast 2024 - 2032

出版日期: 2024年03月01日 | 出版商:

Global Market Insights Inc. | 英文 75 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2024 年至 2032 年，全球气喘间隔器市场规模将实现 5.5% 的复合年增长率，这归因于吸入器技术的进步和医疗保健基础设施的扩展，以及对间隔器益处的认识的提高。现代吸入器需要相容的垫片以实现最佳药物输送，并增加医疗机构的使用机会，导致需求不断增长。随着患者和医疗保健提供者认识到垫片在提高药物有效性方面的优势，市场将会扩大。这些因素凸显了气喘间隔物产业的光明前景，可以满足全球气喘患者的需求。

例如，2023 年 5 月，南非过敏基金会 (AFSA) 向南非市场推出了新型间隔装置 AfriSpacer。这项进展凸显了为提高获得有效气喘治疗方案所做的努力，可能会影响气喘间隔物市场的全球趋势和策略。

气喘间隔物产业根据产品类型、分销管道和地区进行分类。

零售药局部门将在 2032 年获得可观的市场份额，这得益于零售药局为气喘患者购买间隔器提供的便利性和可及性。随着全球气喘盛行率不断上升，零售药局在分发这些基本设备方面发挥着至关重要的作用。它们在社区中广泛存在，再加上获得处方和药剂师指导的便利性，使得零售药局成为购买气喘间隔器的首选。随着对可靠且易于使用的气喘管理解决方案的需求不断增长，零售药房领域将保持其在市场上的主导地位。

由于大容量气喘垫片在有效性和用户友善性方面享有盛誉，到 2032 年，大容量气喘垫片的市场份额将获得可观的成长。医疗保健提供者和患者都更喜欢 Volumatic 储雾罐，因为它具有易于使用和与各种吸入器相容等特点。随着全球对可靠、高效的垫片的需求不断增长，大批量的垫片市场将保持其突出地位。其在促进最佳药物传递方面的记录及其在医疗保健环境中的广泛采用使其成为值得信赖和抢手的选择，巩固了其在哮喘间隔物市场中的关键地位。

2024 年至 2032 年间，亚太地区气喘间隔物市场将以显着的复合年增长率成长。随着人口的增长和医疗保健支出的增加，对有效的气喘管理解决方案的需求不断增加。医疗保健组织的宣传活动和措施也对推动市场发挥了作用。随着亚太地区继续优先考虑呼吸健康，其在气喘垫片行业的主导地位将持续存在，使其成为市场扩张的主要贡献者。

产业生态系统分析
产业影响力
- 成长动力
  - 慢性呼吸道疾病盛行率不断上升
  - 气喘间隔器领域的技术进步
  - 人们越来越认识到垫片的好处
  - 加大产品创新研发投入
- 产业陷阱与挑战
  - 设备成本高
  - 对设备缺乏认识
成长潜力分析
监管环境
技术景观
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
竞争定位矩阵
战略展望矩阵

第 5 章：市场估计与预测：按产品类型，2018 年 - 2032 年

主要趋势
空气舱
视室
体积
灵感
其他产品类型

第 6 章：市场估计与预测：按配销通路划分，2018 年 - 2032 年

主要趋势
医院药房
零售药局
网路药局

第 7 章：市场估计与预测：按地区划分，2018 年 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区

第 8 章：公司简介

Cipla Inc.
GlaxoSmithKline plc
Koninklijke Philips N.V.
Koo Medical Equipment
Laboratoire ProtecSom
Lupin Limited
Mediacare Equipments (India) Pvt. Ltd.
Monaghan Medical Corporation
PARI GmbH
Rossmax International Ltd.
Teleflex Incorporated

简介目录

Product Code: 8354

Global Asthma Spacers Market size will register a 5.5% CAGR from 2024 to 2032, attributed to advancements in inhaler technology and the expansion of healthcare infrastructure, coupled with heightened awareness of spacer benefits. Modern inhalers requiring compatible spacers for optimal drug delivery and increased access to healthcare facilities contribute to rising demand. As patients and healthcare providers recognize the advantages of spacers in improving medication effectiveness, the market will expand. These factors underscore a promising future for the asthma spacers industry, catering to the needs of asthma patients worldwide.

For instance, in May 2023, the Allergy Foundation of South Africa (AFSA) introduced AfriSpacer, a new spacer device, to the market in South Africa. This development highlights efforts to enhance access to effective asthma treatment options, potentially influencing global trends and strategies in the asthma spacers market.

The asthma spacers industry is classified based on product type, distribution channels, and region.

The retail pharmacies segment will secure a substantial market share by 2032, fueled by the convenience and accessibility of retail pharmacies for asthma patients to purchase spacers. With the rising prevalence of asthma worldwide, retail pharmacies play a crucial role in distributing these essential devices. Their widespread presence in communities, in line with the ease of obtaining prescriptions and guidance from pharmacists, makes retail pharmacies a preferred choice for asthma spacer procurement. As the demand for reliable and accessible asthma management solutions grows, the retail pharmacies segment will maintain its dominant position in the market.

The asthma spacers market share from the volumatic segment will amass considerable gains by 2032 due to the established reputation of volumatic asthma spacers for effectiveness and user-friendliness. Healthcare providers and patients alike prefer the Volumatic spacer for its features like ease of use and compatibility with various inhalers. As the demand for reliable and efficient spacers rises globally, the volumatic segment will maintain its prominence. Its track record of facilitating optimal drug delivery and its widespread adoption in healthcare settings position it as a trusted and sought-after choice, solidifying its pivotal position in the asthma spacers market.

Asia Pacific asthma spacers market will grow at a notable CAGR between 2024 and 2032. This region witnesses a high burden of asthma cases, driven by factors like rising pollution levels and lifestyle changes. With a growing population and increasing healthcare expenditures, there is a heightened demand for effective asthma management solutions. Awareness campaigns and initiatives by healthcare organizations also play a role in boosting the market. As Asia Pacific continues to prioritize respiratory health, its dominance in the asthma spacers industry will persist, making it a primary contributor to market expansion.

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of chronic respiratory conditions
  - 3.2.1.2 Technological advancements in the field of asthma spacers
  - 3.2.1.3 Growing awareness regarding the benefits of spacers
  - 3.2.1.4 Rising investment in R&D for product innovation
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of devices
  - 3.2.2.2 Lack of awareness regarding the devices
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Aerochamber
5.3 Optichamber
5.4 Volumatic
5.5 Inspirease
5.6 Other product types

Chapter 6 Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Hospital pharmacies
6.3 Retail pharmacies
6.4 Online pharmacies

Chapter 7 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Italy
- 7.3.5 Spain
- 7.3.6 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 Saudi Arabia
- 7.6.2 South Africa
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa